Last edition
News about Market
Hongene Biotech Supports SiranBio's Dual-Target siRNA Programme for Chronic Hepatitis B
Hongene Biotech provided end-to-end CDMO support for SiranBio’s SA1211 siRNA candidate, highlighting its capabilities in complex oligonucleotide therapeutic development and manufacturing.
Market | 11/05/2026 | By News Bureau | 245
P&G Health Launches Neurobion Nerve Pain Relief Cream for Targeted Symptomatic Relief
P&G Health introduces a specialised topical cream with capsaicin and soothing ingredients to help manage nerve-related pain, tingling and burning sensations in hands and feet.<br />
Market | 08/05/2026 | By News Bureau
Merck Becomes Sole Testing Provider for FDA-Approved Gene Therapies of Genetix Biotherapeutics
Merck signs a 5-year deal as sole testing provider for Genetix Biotherapeutics’ gene therapies, delivering end-to-end testing to support safe, reliable commercialisation of advanced therapies.
Market | 08/05/2026 | By News Bureau | 238
Neuland Laboratories partnership with LIR Life Sciences Corp will focus on developing and manufacturing cell-penetrating peptides to support LIR Life’s patch-based GLP-1/GIP obesity treatment platform.
Market | 07/05/2026 | By News Bureau | 269
Bayer to Acquire Perfuse Therapeutics to Boost Ophthalmology Pipeline
Bayer to acquire Perfuse Therapeutics, strengthening its ophthalmology pipeline with a potential disease-modifying therapy for glaucoma and diabetic retinopathy.
Market | 07/05/2026 | By News Bureau | 124
Tissue Dynamics and Galmed Pharmaceuticals partner to develop a human-centered cardiac fibrosis platform that will focus on chronic post-MI remodeling and HFpEF, linking lipid metabolism, SCD1 activity, fibrosis, and impaired tissue repair.
Market | 07/05/2026 | By News Bureau | 136
Viralgen Partners with Elaaj Bio to Advance Gene Therapy for CDKL5 Deficiency Disorder
Viralgen partners with Elaaj Bio to advance an AAV-based gene therapy program for CDKL5 Deficiency Disorder, leveraging specialised manufacturing expertise.
Market | 06/05/2026 | By News Bureau | 246
Merck Completes USD 5.8 Billion Acquisition of Terns Pharmaceuticals to Strengthen Oncology Pipeline
Merck acquires Terns Pharmaceuticals, advancing development of next-generation therapies for chronic myeloid leukaemia.
Market | 06/05/2026 | By News Bureau | 175
Accord Healthcare US Relaunches Tadalafil Tablets with Expanded Dosage Availability
Accord Healthcare US relaunches Tadalafil tablets with expanded dosage strengths to improve access for treating Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia (BPH), including ED/BPH combination therapy.
Market | 05/05/2026 | By News Bureau | 139
Eton Pharmaceuticals Relaunches HEMANGEOL (Propranolol) Oral Solution
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Anovo Specialty Pharmacy distribution and Eton Cares support, improving access to the only FDA-approved treatment for infantile hemangioma.
Market | 05/05/2026 | By News Bureau | 178
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy